The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 29, 2020

Filed:

Sep. 22, 2015
Applicant:

Dingfu Biotarget Co., Ltd., Jiangsu, CN;

Inventors:

Ting Xu, Jiangsu, CN;

Yan Luan, Jiangsu, CN;

Xiaoxiao Wang, Jiangsu, CN;

Jianjian Peng, Jiangsu, CN;

Shuli Ma, Jiangsu, CN;

Hui Ma, Jiangsu, CN;

Xiaolong Pan, Jiangsu, CN;

Shilong Fu, Jiangsu, CN;

Shanshan Ning, Jiangsu, CN;

Yeqiong Fei, Jiangsu, CN;

Meng Zhao, Jiangsu, CN;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); C12N 15/13 (2006.01); C12N 15/12 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); A61K 39/395 (2013.01); A61K 45/06 (2013.01); C07K 16/28 (2013.01); A61P 35/00 (2018.01); C07K 2317/31 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/74 (2013.01); C07K 2317/75 (2013.01);
Abstract

Disclosed are a fully human monoclonal antibody specifically binding to a CD137 or an antigen binding portion thereof. On one hand, provided are a CDR/variable region sequence of the antibody and an encoding nucleic acid sequence thereof; on the other hand, provided is a method for treating diseases using the antibody or the antigen binding portion thereof. a fully human monoclonal antibody specifically binding to a CD137 or an antigen binding portion thereof. On one hand, provided are a CDR/variable region sequence of the antibody and an encoding nucleic acid sequence thereof; on the other hand, provided is a method for treating diseases using the antibody or the antigen binding portion thereof.


Find Patent Forward Citations

Loading…